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Aims Excessive arterial pulsatility may contribute to cognitive decline and risk of dementia via damage to the fragile cere-
bral microcirculation. We hypothesized that the intensity of downstream-travelling pulsatile waves measured by
wave intensity analysis in the common carotid artery during mid- to late-life would be associated with subsequent
cognitive decline.
...................................................................................................................................................................................................
Methods
and results
Duplex Doppler ultrasound was used to calculate peak forward-travelling compression wave intensity (FCWI)
within the common carotid artery in 3191 individuals [mean ± standard deviation (SD), age = 61 ± 6 years; 75%
male] assessed as part of the Whitehall II study in 2003–05. Serial measures of cognitive function were taken
between 2002–04 and 2015–16. The relationship between FCWI and cognitive decline was adjusted for sociode-
mographic variables, genetic and health-related risk factors, and health behaviours. Mean (SD) 10-year change in
standardized global cognitive score was -0.39 (0.18). Higher FCWI at baseline was associated with accelerated cog-
nitive decline during follow-up [difference in 10-year change of global cognitive score per 1 SD higher
FCWI = -0.02 (95% confidence interval -0.04 to -0.00); P= 0.03]. This association was largely driven by cognitive
changes in individuals with the highest FCWI [Q4 vs. Q1–Q3 = -0.05 (-0.09 to -0.01), P= 0.01], equivalent to an age
effect of 1.9 years. Compared to other participants, this group was 50% more likely to exhibit cognitive decline
(defined as the top 15% most rapid reductions in cognitive function during follow-up) even after adjustments for
multiple potential confounding factors [odds ratio 1.49 (1.17–1.88)].
...................................................................................................................................................................................................
Conclusion Elevated carotid artery wave intensity in mid- to late-life predicts faster cognitive decline in long-term follow-up in-
dependent of other cardiovascular risk factors.
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Introduction
Cognitive impairment and dementia are major contributing factors to
morbidity and mortality in the elderly, but the causes and risk factors
responsible for their development are still poorly understood. With
the worldwide incidence of dementia projected to triple within the
next 30 years,1 the identification of mechanistic pathways responsible
for its progression is vital for preventive strategies aiming to reduce
disease prevalence in an ageing population.
Recent cross-sectional2–5 and prospective6–8 studies suggest a po-
tential link between arterial phenotypes in mid-life and the develop-
ment of adverse structural brain changes, accelerated cognitive
decline, and increased risk of dementia.7,9–12 This relationship may
become more pronounced from middle-age, when a combination of
vascular ageing and long-term exposure to cardiovascular disease
(CVD) risk factors interact to augment the intensity of arterial pulsa-
tility via a disproportionate stiffening of the aorta and the subsequent
transmission of excess wave energy into the major arteries supplying
the brain.13,14 While this association is supported by studies using
surrogate markers such as aortic pulse-wave velocity and carotid
pulse pressure (PP),2,6,7,11 a direct relationship between the likely
mechanism responsible for downstream small vessel damage—an in-
crease in the intensity of pulsatile waves travelling through the carotid
arteries towards the brain—and future cognitive decline has never
been examined.
We, therefore, investigated this relationship in a large cohort of
adults recruited to the Whitehall II study; an ongoing longitudinal
study of >3000 participants with novel carotid wave intensity meas-
ures performed in mid- to-late-life and in whom serial measures of
cognitive function were available over 11–14 years of follow-up. We
hypothesized that the peak intensity of the carotid artery forward-
travelling compression wave in mid- to late-life would be associated
with subsequent cognitive decline, and in particular that those with
the highest forward compression wave intensity (FCWI) would ex-
hibit the most pronounced decline in cognitive function, independent
of other well-established cardiovascular risk factors.
Methods
Study population
The Whitehall II Study is an ongoing cohort study of persons originally
employed by the British Civil Service, full details of which have been
reported previously.15 A total of 10 308 persons aged 33–55 years (67%
male) were recruited to the study between 1985 and 1988. All partici-
pants responded to a comprehensive questionnaire and underwent a uni-
form, structured clinical evaluation, consisting of measures of
anthropometry, cardiovascular and metabolic risk factors, and disease.
Since baseline, follow-up examinations—which since 1997 (Phase 5) have
additionally included tests of cognitive function—have taken place ap-
proximately every 5 years, with the most recent visit completed in 2015–
16. In addition to official 5-year clinic visits, participants active in the study
during the Phase 7 clinical examination (2002–04) were invited for a vas-
cular clinic visit in 2003–05, in which wave intensity was measured in the
carotid artery using duplex Doppler ultrasound. In the current analyses,
we included only individuals with baseline measures of carotid wave in-
tensity in 2003–05 and longitudinal measures of cognitive function
assessed between 2002–04 and 2015–16 (Figure 1). All participants
provided written consent prior to commencing the study. All protocols
were approved by the University College London ethics committee and
conformed to the Declaration of Helsinki.
Wave intensity analysis
Carotid artery wave intensity (WI) was measured in 4105 participants
(age 51–73 years, 75% male) attending a specialist vascular clinic con-
ducted 1 year after the Phase 7 clinic. All participants who attended
Phase 7 were invited to return to the WI clinic, and a comparison of
those who accepted or refused is provided in Supplementary material on-
line, Table S1. Intra-session intra- and inter-observer reproducibility analy-
ses were conducted in a subset of participants (n= 39) and were in
agreement with values reported in the literature (coefficient of var-
iation = 10% and 19% for intra- and inter-observer repeat scans,
respectively).
Full details of the WI technique and its clinical applicability have been
published elsewhere.16 In brief, WI analysis provides a non-invasive meas-
ure of the net energy flux carried by forward- and backwards-travelling
waves within the arterial system. During each cardiac cycle, left ventricu-
lar contraction results in the generation of a large forward-travelling com-
pression wave in early systole, when blood velocity and pressure increase
in tandem. This is often followed shortly afterwards by a reflected
backwards-travelling compression wave in mid-systole—slowing velocity
while continuing to increase pressure—and finally a forward-travelling
expansion wave generated by the onset of left ventricular relaxation at
the end of systole (Figure 2). For the purposes of this study, the peak in-
tensity of the initial compression wave travelling towards the brain during
early systole—i.e. FCWI—was our main focus. All measurements of
FCWI were made using a colour Doppler ultrasound system (SSD-500,
Aloka, Tokyo, Japan) fitted with a 7.5 MHz linear array probe.
Independently, steerable ultrasound beams were used to measure simul-
taneous changes in arterial diameter and blood velocity in the common
carotid artery at a site located 2 cm proximal to the carotid bulb
(Figure 2). Automated software (Aloka, Tokyo, Japan) was then used to
convert changes in diameter to estimates of pressure within the vessel
(calibrated using brachial blood pressure). Time-normalized FCWI was
calculated as the product of the time derivatives of the concurrent blood
pressure (dP/dt) and velocity (dU/dt) waveforms.17 Measures were taken
in both left and right carotid arteries, and the mean was used for analyses.
Carotid artery structure and stiffness
In addition to WI measures, multiple measures of carotid structure and
stiffness collected during the Phase 7 clinic (2002–04) were assessed in
order to investigate the relationship between other carotid phenotypes
and cognitive decline. Full details of these measures can be found in the
Supplementary material online, File S1.
Blood pressure
Ipsilateral systolic and diastolic blood pressures (SBP and DBP, respect-
ively) were measured in the supine position using an OMRON M5-I digit-
al sphygmomanometer at the time of each WI assessment. Two
measures of SBP and DBP were taken and their mean was used. Pulse
pressure was calculated as SBP - DBP, and mean arterial pressure was cal-
culated as DBPþ (PP/3).
Cognitive function
The cognitive test battery was introduced to the study in 1997 and has
been repeated a further four times until 2016. In the current study,
change in cognitive function was assessed using all four phases of data col-
lected in clinical examinations between 2002–04 and 2015–16 (Phases 7,
9, 11, and 12). The test battery was carried out in a single-session at each
2 S.T. Chiesa et al.
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..time point and provides a comprehensive assessment of cognitive func-
tion covering memory, executive function, and fluency. The primary out-
come of this study was a global measure of cognitive function
incorporating all tests described above. More details on all cognitive
measures can be found in the Supplementary material online, File S1.
Covariates
Full details of all sociodemographic variables, genetic risk factors, health
behaviours, and health-related covariates can be found in the
Supplementary material online, File S1.
Statistical analysis
Linear mixed models were used to estimate the association of carotid
FCWI with change in global cognitive scores and the individual
cognitive domains across the four phases of data collection between
2002–04 and 2015–16. These models use all available cognitive func-
tion data and account for the correlation between repeated measures
within individuals. The intercept and slope were fitted with time as
random effects for individual differences in cognitive function at base-
line and rate of change of cognitive function scores over the follow-up.
Associations of carotid FCWI with cognitive decline were estimated
by fitting FCWI by time interaction terms in the models. Tests for
interaction between sex and FCWI were all non-significant (P> 0.20).
All analyses were therefore conducted with men and women com-
bined, while adjusting for possible confounding effects of sex, age (lin-
ear and squared terms), ethnicity, and education by fitting these terms
and their interactions with follow-up time. The models were fitted to
estimate change in cognitive function over a 10-year period. Initial
Full Whitehall II cohort 
 (Phase 1) 1985-1988 
N = 10308 
Deaths prior to Phase 7, N = 584
Drop-outs / non-responder at Phase 7, N = 2757
Cognive change not calculated:
No cognive funcon at baseline (Phase 7), N=59
Cognive funcon measured only at baseline, N=208
Did not have WI measures, N = 2378
Study sample at baseline (Phase 7) with known 
WI and cognive change over me  
N = 3448
Parcipants with carod phenotypes measured 
2003-2005 
 N = 4105 
Parcipated at Phase 7 (clinic or quesonnaire) 
2002-2004 
N = 6967 
Parcipated at Phase 7 clinic 
N = 6483 
Completed Phase 7 quesonnaire only, did not 
aend clinic, N=484
Parcipants with WI and ≥1 measure of cognive 
funcon at Phases 7, 9, 11 or 12  
N = 3715 
WI measure missing, N=358 
No cognive measures at any of  
Phases 7, 9, 11 or 12, N = 84
Final study sample (Phase 7) 
N = 3191
Missing covariates at baseline (Phase7), N=257
Figure 1 A cohort flowchart.
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.analyses used FCWI as a continuous measure, and then to test our hy-
pothesis of greater effects of high FCWI, subsequent analyses exam-
ined the form of the association across levels of FCWI by categorizing
the distribution into quartiles and then comparing participants with
the highest 25% of FCWI with the remaining 75%.
In order to examine FCWI as a predictor of the most pronounced
cognitive decline, we used the linear mixed model above, with no covari-
ates, to estimate cognitive decline across the four waves of data collec-
tion for each participant. The 15% of participants with the greatest
cognitive declines were categorized as having the binary outcome of
Figure 2 Representative image of a carotid wave intensity measurement performed using Doppler ultrasound. Representative trace showing out-
put of carotid wave intensity analysis calculated from simultaneous non-invasive ultrasound measures of blood velocity (bottom left) and vessel diam-
eter (bottom right). BCW, backwards compression wave; ECG, electrocardiogram; FCW, forward compression wave; FEW, forward expansion
wave.
4 S.T. Chiesa et al.
D
ow
nloaded from
 https://academ
ic.oup.com
/eurheartj/advance-article-abstract/doi/10.1093/eurheartj/ehz189/5428554 by Sw
ansea U
niversity user on 10 April 2019
......................................................................................................
....................................................................................................................................................................................................................
Table 1 Baseline characteristics of 3191 participants in the study sample according to quartiles of carotid forward
compression wave intensity
Mean (SD) or % P-value for
heterogeneityBaseline carotid FCWI quartile
Quartile 1
(lowest)
Quartile 2 Quartile 3 Quartile 4
(highest)
Carotid FCWI range (mmHg.m/s3) <6075 6075–8149 8150–10 949 >10 949
Number 781 813 811 786
Age (years) 61.2 (5.8) 60.3 (5.6) 60.7 (5.8) 60.8 (5.9) 0.01
Female (%) 39.1 26.2 18.3 17.1 <0.001
Ethnicity 0.07
White 92.3 94.1 93.5 93.0
Non-White 7.7 5.9 6.5 7.0
BMI (kg/m2) <0.001
Underweight (<20.0) 4.4 3.6 2.2 2.2
Normal weight (20.0–24.9) 39.8 36.8 38.2 28.1
Overweight (25.0–29.9) 38.9 38.2 45.5 48.4
Obese (>_30.0) 16.9 28.1 14.1 21.4
Carotid FCWI (mmHg.m/s3) 4795 (923) 7115 (582) 9401 (780) 14 949 (4563) <0.001
Blood pressure (mmHg)a
Systolic blood pressure 122.7 (12.9) 127.4 (13.8) 130.3 (13.4) 137.0 (14.2) <0.001
Pulse pressure 44.9 (7.3) 49.5 (7.3) 52.7 (7.6) 58.4 (8.8) <0.001
Diastolic blood pressure 77.8 (8.6) 78.0 (9.2) 77.6 (8.8) 78.6 (8.9) 0.18
Mean arterial pressure 92.8 (9.6) 94.5 (10.4) 95.2 (9.9) 98.0 (10.1) <0.001
Education 0.09
<_Lower secondary 37.9 34.3 31.3 32.2
Higher secondary 27.3 28.5 29.5 27.2
>_Degree 34.8 37.2 39.2 40.6
Employment grade 0.01
High 44.6 49.2 50.1 51.2
Intermediate 45.8 43.9 44.8 41.6
Low 9.6 6.9 5.2 7.3
Smoking habit 0.02
Never 49.3 47.5 47.0 52.3
Ex-smoker 42.3 46.0 45.9 43.3
Current 8.5 6.5 7.2 4.5
Alcohol consumption 0.36
No alcohol 15.5 13.0 11.8 12.5
Moderate alcohol 64.3 65.7 68.7 66.4
Heavy alcohol 20.2 21.3 19.5 21.1
Moderate or vigorous physical activity (h/week) 0.67
<1 20.2 20.4 21.5 21.8
1–6.9 62.3 63.6 61.8 64.1
>_7 17.4 16.0 16.8 14.1
GHQ caseness (%) 19.6 17.3 19.4 20.1 0.51
Hypertension (%) 33.0 29.6 35.0 44.8 <0.001
Diabetes (%) 5.8 4.3 6.5 10.6 <0.001
Atrial fibrillation (%) 1.9 1.0 0.1 0.9 0.004
History of CVD (%) 6.9 5.3 6.4 5.2 0.39
Physical component score 48.6 (8.9) 49.7 (8.3) 50.0 (7.6) 50.0 (7.6) <0.001
aBlood pressure measured at the time when carotid wave intensity was measured.
BMI, body mass index; CVD, cardiovascular disease; FCWI, forward compression wave intensity; GHQ, general health questionnaire.
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interest. Logistic regression models were fitted and odds ratios (95% con-
fidence intervals) calculated to estimate the association between FCWI
and the fastest rate of cognitive decline. These models were initially
adjusted for age and sex and a series of further models were fitted that
additionally adjusted for other covariates. To assess the robustness of
our findings, sensitivity analyses were conducted where threshold for the
proportion of participants with the fastest cognitive decline was varied
between 10 and 25%. Statistical significance was inferred at a two-tailed
P-value <0.05.
Results
Participant characteristics
Sample selection is shown in Figure 1 and full demographic and clinical
characteristics are shown in Table 1. Of the 10 308 participants at
study inception, 4105 had FCWI evaluated in 2003–05, and 3191 of
these had at least two measures of cognitive function between 2002–
04 and 2015–16 (four measures, n= 2499; three measures, n= 419;
and two measures, n= 273). The final sample of 3191 individuals was
predominantly white (93%) and male (75%), with a mean age of
60.7± 5.8 years at the measurement of FCWI.
Associations between forward
compression wave intensity measured in
mid- to late-life and changes in cognitive
function
Mean [standard deviation (SD)] 10-year decline in standardized glo-
bal cognitive score was 0.39 (0.18). In linear mixed models adjusting
for age, age-squared, sex, ethnicity, and education; increased FCWI at
baseline was independently associated with a decrease in global cog-
nitive score during prospective follow-up [difference in 10-year
change in score per 1 SD increase in FCWI = -0.02 (-0.04 to -0.00);
P= 0.03]. Other markers of carotid structure and stiffness showed
no association with any measures of cognitive function
(Supplementary material online, Table S2).
When stratified by quartiles of FCWI, this decline was observed
only in individuals with the highest FCWI at baseline [difference in
10-year change in score for Q2, Q3, and Q4 vs. Q1 = 0.01 (-0.04 to
0.06), P= 0.77; -0.01 (-0.06 to 0.04), P= 0.69; and -0.05 (-0.10 to
0.00), P= 0.04, respectively; Table 2 and Figure 3]. As a result, individu-
als with the highest levels of FCWI (Q4) displayed a 13% [(-0.05/
-0.38)  100] greater decline in cognitive function [-0.05 (-0.10 to
-0.01), P= 0.01] than the rest of the cohort combined (Q1–Q3),
equivalent to an age effect of 1.9 years. Changes in executive function
[AH4 -0.04 (-0.07 to -0.00); 29% greater; P= 0.03] and phonemic flu-
ency [-0.09 (-0.14 to -0.03); 39% greater; P= 0.004] appeared to
underlie this decline (Table 2). Adjustment for ApoE genotype had no
effect on this relationship, and there was no evidence for any inter-
action between these two factors and cognitive outcomes.
In analysis of rapid cognitive decline as the outcome (binary vari-
able of top 15% vs. rest), individuals with the highest FCWI (Q4) in
mid- to late-life were almost 50% more likely to exhibit rapid declines
in cognitive function during prospective follow-up [OR = 1.49 (1.21–
1.83)], with these findings once again remaining unchanged following
adjustment for all covariates [OR = 1.49 (1.17–1.88); Table 3].
Sensitivity analyses assessing different cut-offs for cognitive decline at
10, 15, 20, and 25% were also conducted and were broadly consist-
ent with main findings, with full results provided in Supplementary
material online, Table S4.
Discussion
In this longitudinal study of over 3000 individuals, we show that
increased carotid FCWI in mid- to late-life is associated with greater
10-year cognitive decline. Stratification into quartiles of FCWI
revealed a threshold effect for this relationship, with individuals in the
highest quartile for FCWI at baseline observed to have 50% greater
odds of rapid cognitive decline compared to the rest of the cohort.
Importantly, this risk remained unchanged following adjustments for
multiple potential confounding factors such as demographic and edu-
cational differences, genetic risk factors, hypertension and other
CVD risk factors, and health-related behaviours.
Increasing evidence suggests that the disease process underlying
the development of dementia, both Alzheimer’s and other forms,
may begin decades before the first signs of overt cognitive impair-
ment.18 Recent findings from both Whitehall II and other studies
have shown that this process is likely accelerated by exposure to car-
diovascular risk factors such as dyslipidaemia, diabetes, history of
CVD, arrhythmias (atrial fibrillation), smoking, alcohol use, and hyper-
tension.10,19–22 From mid-life onwards, the most common form of
hypertension is isolated systolic hypertension—a condition attrib-
uted to a reduction in aortic compliance and characterized by an in-
crease in SBP, a progressive decrease in DBP, and a widening of PP.
These changes are a consequence of structural alterations within the
major elastic arteries—particularly the aorta—and may result in an
increased penetrance of pulsatile pressure and flow into the fragile
microcirculation of the brain and the subsequent development of
cerebral small vessel disease.13 Greater burden of cerebral small ves-
sel disease, in turn, has been linked to parenchymal atrophy and the
Figure 3 Change in 10-year global cognitive z-score per quartile
of carotid forward compression wave intensity. FCWI, forward
compression wave intensity. Means are adjusted for age, sex, ethni-
city, and education and are presented for white men aged 60 years
with tertiary education. *P-value = 0.04 (comparing Quartile 4 with
Quartile 1).
6 S.T. Chiesa et al.
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development of amyloid plaques, neuroinflammation, and neurofibril-
lary tangles which are commonly observed in the advanced stages of
vascular dementia and Alzheimer’s disease, respectively.14
Previous research from the Conduit Haemodynamics of
Omapatrilat International Research Study (CHOIR) has suggested
that increased forward-travelling compression waves due to elevated
aortic characteristic impedance is the predominant factor underlying
the increases in PP commonly observed from mid-life, with this phe-
nomenon involving a combination of aortic remodelling and progres-
sive increases in aortic stiffness that commonly occur in middle-age.23
While several smaller cross-sectional and some prospective studies
have shown relationships between surrogate markers of arterial stiff-
ness/pulsatility and cognitive performance2–8; no previous study to
date has directly investigated the relationship between the intensity
of these compression waves approaching the brain and cognitive de-
cline. In order to assess directly this relationship, we used carotid
wave intensity analysis—a non-invasive technique that allows the for-
wards- and backwards-travelling waves within the major arteries sup-
plying the brain to be separated—to quantify the peak rate of energy
transfer transmitted towards the fragile cerebral microcirculation
with each beat of the heart.17
This novel technique has enabled us to conduct a large-scale study
of the relationship between FCWI and cognitive outcomes in an
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Table 3 Association between high baseline carotid
forward compression wave intensity and accelerated
cognitive decline during follow-up
Baseline FCWI
(N5 3191)
Lowest 75%
(N52405)
Highest 25%
(N5 786)
Outcome The 15% of participants
with the greatest cog-
nitive decline over the
follow-up
341 (14.2%) 155 (19.7%)
Model Adjustments Odds ratio (95% CI)
M0 Unadjusted 1.0 1.49 (1.21, 1.83)
M1 M0þ age, sex 1.0 1.51 (1.21–1.88)
M2 M1þ ethnicity, educa-
tion, employment
grade
1.0 1.51 (1.21–1.88)
M3 M2þ smoking, alcohol
consumption, physical
activity
1.0 1.50 (1.20–1.87)
M4 M3þ systolic blood
pressure
1.0 1.51 (1.20–1.91)
M5 M4þGHQ caseness,
hypertension, dia-
betes, BMI category,
history of CVD, atrial
fibrillation, physical
component score
1.0 1.49 (1.17–1.88)
BMI, body mass index; CVD, cardiovascular disease; FCWI, forward compression
wave intensity; GHQ, general health questionnaire.
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extensively-phenotyped longitudinal cohort. We have shown that
individuals with higher carotid FCWI in mid- to late-life are at greater
risk of accelerated cognitive decline during 11–14-year follow-up.
Importantly, although higher FCWI was associated with a number of
other mid-life CVD risk factors also associated with dementia (e.g.
increased body mass index, systolic hypertension, diabetes),24 adjust-
ment for these and other potential confounding factors had little im-
pact on the relationship between FCWI and decline in cognitive
function. Furthermore, this association did not appear to result from
structural and functional changes within the carotid artery itself, as no
relationship was observed between any carotid phenotype and cog-
nitive decline. These findings support previous work suggesting that
an increase in forward wave amplitude within the carotid arteries is
likely attributable to altered ventricular dynamics and/or dispropor-
tionate changes in aortic characteristic impedance or compli-
ance,23,25,26 as opposed to increases in carotid stiffness per se.
Together, these findings suggest that exposure to increased wave in-
tensity in mid- to late-life may contribute to the observed association
between arterial stiffness in mid-life and risk of dementia in the fol-
lowing decades, and that this relationship cannot be detected using
common carotid phenotypes.
There are a number of strengths in our study to support this hy-
pothesis. Firstly, the Whitehall II cohort represents the largest and
most extensively characterized population to date containing both
carotid wave intensity measures collected during mid- to late-life and
long-term serial measures of cognitive function assessed throughout
old age. Although the observational nature of this cohort meant it
was not possible to infer causal associations between exposures and
outcomes, it provided a unique opportunity to investigate—for the
first time—the likely haemodynamic mechanisms linking increased
blood pressure to cerebral small vessel disease. These data may pro-
vide insight into the potential mechanistic process underlying recent
results from the SPRINT-MIND trial, in which the risk for mild cogni-
tive impairment was reduced following intensive blood pressure
treatment.27 Secondly, the extensive phenotyping of individuals col-
lected over four decades in the Whitehall II study, alongside high re-
tention rates, allowed these relationships to be tested independently
of a wide-range of genetic, social, and health-related risk factors
which have previously been linked to future incidence of dementia in
this cohort, and which may have therefore confounded results.10,20–
22,28 Thirdly, although the limited numbers of participants with WI
measures (50% of Phase 7 population) meant that our study was
not adequately powered to investigate dementia itself as a primary
outcome, an accelerated decline in the global cognitive score
employed in this study has previously been shown to occur in the
8–10 years prior to a diagnosis of dementia.10 This score therefore
provides an earlier-detectable and clinically relevant measure of dis-
ease progression that may be targeted in interventional studies long
before clinical diagnosis of dementia. In addition, the emergence of
phonemic fluency as the predominant factor underlying these
changes supports previous findings from this cohort linking arterial
pulsatility to cognitive decline, with prospective changes in this cogni-
tive domain found to be most closely related to high levels of SBP in
women, and to be the only domain linked to SBP in men, during early
middle-age (mean age 44± 6 years).28 There are a number of poten-
tial limitations to the current study. Firstly, given the predominantly
white (93%) and male (75%) demographic of the Whitehall II cohort,
future studies reproducing these findings in female or more ethnically
Take home ﬁgure Elevated carotid artery wave intensity in mid- to late-life predicts faster cognitive decline in long-term follow-up independ-
ent of other cardiovascular risk factors.
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diverse cohorts are required in order to establish whether this meas-
ure may potentially impact future clinical practice. Secondly, signifi-
cant cohort differences exist between participants who responded
to the invitation to attend the WI clinic and those who did not.
However, as those in attendance tended to be healthier overall, it is
not unreasonable to predict that the changes observed here would
be likely to be equivalent or even greater in the cohort as a whole.
Thirdly, brain imaging was not available in all members of this cohort,
and it was therefore not possible to relate cerebral structural and
functional changes to cognitive decline. However, future work in a
sub-sample of600 participants from this cohort who have recently
undergone detailed MRI scans and are now being recalled for repeat
testing are expected to shed future light on these relationships.29
Finally, the use of brachial blood pressure as a surrogate for carotid
blood pressure may have introduced a source of bias when calculat-
ing wave intensity. However, these measures have previously been
shown to be equivalent in elderly populations, making this an unlikely
limitation.16
Our findings provide support for a link between cardiovascular
health in mid- to late-life and risk of dementia in later life, and there-
fore, have important clinical implications. Given the well-publicized
failure of multiple Phase III dementia outcome trials carried out in the
later stages of the disease,30,31 our findings highlight the importance
of early strategies to slow or prevent vascular disease and cognitive
decline.
In conclusion, we provide the first evidence of a link between the
proposed mechanism hypothesized to cause cerebral small vessel
damage (i.e. increased wave intensity transmitted into the cerebral
circulation) and an accelerated decline in cognitive function. In add-
ition, as FCWI remained an independent predictor of future cognitive
decline even after adjustment for an extensive range of potential con-
founding factors, interventions to lower carotid FCWI may hold
promise for delaying or preventing the onset of cognitive decline.
Supplementary material
Supplementary material is available at European Heart Journal online.
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